Another urgent task is expanding LAMP2 mutation screening in male patients with unexplained cardiomyopathy – particularly those with hypertrophic cardiomyopathy (HCM) and elevated CK. This evidence concerns the gene LAMP2 and hypertrophic cardiomyopathy.